Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragmin for Thromboprophylaxis in Esophageal Cancer Surgery
NCT05067153Phase 4Unknown
- Sponsor
- Aarhus University
- Start
- May 2021
- Primary completion
- May 2023
- Countries
- 1
01
Overview
A Phase 4 trial of dalteparin in thrombosis, thromboembolism, sponsored by Aarhus University. Status: unknown.
02
Drugs
dalteparin
03
Conditions
thrombosisthromboembolism
Beyond the preview
Go deeper on NCT05067153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05067153.